share_log

醫渡科技：截至2024年9月30日止六個月的中期業績公告

YIDU TECH: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024

HKEX ·  Nov 21, 2024 01:04

Summary by Moomoo AI

截至2024年9月30日止六個月，醫渡科技的收入為人民幣329.4百萬元，同比下降7.6%。毛利為人民幣117.4百萬元，同比下降13.8%。經營虧損縮減至人民幣54.3百萬元，同比減少30.7%。期間虧損縮減至人民幣56.4百萬元，同比減少29.2%。董事會不建議派發中期股息。管理層指出，收入下降主要受外部市場環境及產品組合變化影響。然而，內部運營效率提升及業務板塊間的協同效應增強，導致虧損縮減。公司在AI技術和醫療領域的深厚積累，推動了技術落地和標準化建設，進一步推動醫療行業的智能轉型。公司現金儲備充足，現金及現金等價物、定期存款等合計為人民幣3,188.7百萬元。展望未來，醫渡科技將繼續優化醫療垂直領域的大語言模型，提升AI醫療大腦YiduCore的功能，推動自研大模型在各個醫療生態場景的落地。公司將加強核心技術投入，深化疾病研究與應用，並通過戰略合作夥伴關係、投資和收購豐富生態系統。
截至2024年9月30日止六個月，醫渡科技的收入為人民幣329.4百萬元，同比下降7.6%。毛利為人民幣117.4百萬元，同比下降13.8%。經營虧損縮減至人民幣54.3百萬元，同比減少30.7%。期間虧損縮減至人民幣56.4百萬元，同比減少29.2%。董事會不建議派發中期股息。管理層指出，收入下降主要受外部市場環境及產品組合變化影響。然而，內部運營效率提升及業務板塊間的協同效應增強，導致虧損縮減。公司在AI技術和醫療領域的深厚積累，推動了技術落地和標準化建設，進一步推動醫療行業的智能轉型。公司現金儲備充足，現金及現金等價物、定期存款等合計為人民幣3,188.7百萬元。展望未來，醫渡科技將繼續優化醫療垂直領域的大語言模型，提升AI醫療大腦YiduCore的功能，推動自研大模型在各個醫療生態場景的落地。公司將加強核心技術投入，深化疾病研究與應用，並通過戰略合作夥伴關係、投資和收購豐富生態系統。
For the six months ended 30 September 2024, Mediado Technology's revenue was RMB329.4 million, down 7.6% year-on-year. Gross profit was RMB117.4 million, down 13.8% year-on-year. Operating loss decreased to RMB54.3 million, down 30.7% year-on-year. The loss for the period decreased to RMB 56.4 million, down 29.2% year-on-year. The Board of Directors does not recommend the distribution of an interim dividend.Management noted that the revenue decline was mainly influenced by the external market environment and changes in product mix. However, improved internal operational efficiency and enhanced synergies between business segments lead to reduced losses. THE COMPANY'S DEEP ACCUMULATION IN AI TECHNOLOGY AND HEALTHCARE HAS DRIVEN TECHNOLOGY GROUNDING AND STANDARDIZED CONSTRUCTION TO FURTHER DRIVE THE INTELLIGENT TRANSFORMATION OF THE HEALTHCARE INDUSTRY...Show More
For the six months ended 30 September 2024, Mediado Technology's revenue was RMB329.4 million, down 7.6% year-on-year. Gross profit was RMB117.4 million, down 13.8% year-on-year. Operating loss decreased to RMB54.3 million, down 30.7% year-on-year. The loss for the period decreased to RMB 56.4 million, down 29.2% year-on-year. The Board of Directors does not recommend the distribution of an interim dividend.Management noted that the revenue decline was mainly influenced by the external market environment and changes in product mix. However, improved internal operational efficiency and enhanced synergies between business segments lead to reduced losses. THE COMPANY'S DEEP ACCUMULATION IN AI TECHNOLOGY AND HEALTHCARE HAS DRIVEN TECHNOLOGY GROUNDING AND STANDARDIZED CONSTRUCTION TO FURTHER DRIVE THE INTELLIGENT TRANSFORMATION OF THE HEALTHCARE INDUSTRY. The company's cash reserves are ample. Cash and cash equivalents, fixed deposits, etc., amount to RMB3188.7 million.Looking ahead, Medtech will continue to optimize the big language models in the medical vertical domain, enhance the capabilities of the AI medical brain YiduCore, and drive self-research large models to the ground in various medical ecological scenarios. THE COMPANY WILL STRENGTHEN CORE TECHNOLOGY INPUTS, DEEPEN DISEASE RESEARCH AND APPLICATIONS, AND ENRICH ECOSYSTEMS THROUGH STRATEGIC PARTNERSHIPS, INVESTMENTS AND ACQUISITIONS.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    GREEN INTL HLDG
    02700
    -- 0.500
    FAMEGLOW
    08603
    -- 1.260
    KN HOSPITAL
    02120
    -- 9.280
    RIMAG GROUP
    02522
    -- 19.280
    NC HEALTHCARE
    01518
    -- 1.250
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    Chinese stock earnings surge: Will profit sustain the rally?
    1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
    China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings